As Easy as ADCC

BioOutsource Lab Image

Extensive regulatory requirements for analytical characterisation are now needed to prove comparability between innovator and biosimilar drugs. As a result, many developers are turning to ADCC assays which can help to unpick the issues of similarity, as well as guide the design process to create molecules to target specific activity. Download our article to find out more about the importance More

Development of a Biosimilar

Associate Director of Technical Services, Catriona Thomson, writes about the development of a biosimilar.

BioOutsource Opens New Facility in Glasgow

BioOutsource Site - Block 1

Doubles the Company’s Capacity for Biologics Contract Testing and Biosimilar Characterisation in Response to Surging Demand, and Creates 50 New Jobs Glasgow, Scotland, July 27, 2015 – BioOutsource Ltd. (“BioOutsource”), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, today announced the opening More

Sartorius Stedim Biotech acquires Cellca

Aubagne, France / Goettingen, Germany, July 2, 2015 – Sartorius Stedim Biotech (SSB), a leading international supplier for the pharma and biotech industries, acquired Cellca GmbH based in Laupheim, Germany, last Wednesday. Founded in 2005, the company with around 30 employees generated sales revenue of approximately 6 million euros in 2014. Cellca’s major customers are More

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.